YM1 produced by macrophages may promote the expression of functional xCT via mTOR signaling in melanoma while mTOR inhibitors, including rapamycin, may promote the sensitivity of tumor cells to γ-ray-induced ROS via the functional attenuation of xCT in tumors. Here, SLC7A11 is linked to melanoma.